ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,353.60
0.00%
S&P ASX All Technology
3,851.00
0.00%
Brent Oil
73.385
2.01%
US Dollar vs AUD
1.56914
0.05%
Bitcoin
101,060.73
4.54%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Acumen Pharmaceuticals Inc (ABOS)

  7. Acumen Pharmaceuticals Inc (ABOS) News

ABOS

Acumen Pharmaceuticals (ABOS)

Acumen Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ABOS
DateTimeSourceHeadlineSymbolCompany
27/11/202408:00GlobeNewswire Inc.Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx ConferenceNASDAQ:ABOSAcumen Pharmaceuticals Inc
13/11/202408:29Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABOSAcumen Pharmaceuticals Inc
12/11/202423:00GlobeNewswire Inc.Acumen Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business HighlightsNASDAQ:ABOSAcumen Pharmaceuticals Inc
12/11/202408:00GlobeNewswire Inc.Acumen Pharmaceuticals to Participate in the Stifel Healthcare ConferenceNASDAQ:ABOSAcumen Pharmaceuticals Inc
07/11/202409:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABOSAcumen Pharmaceuticals Inc
07/11/202409:24Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ABOSAcumen Pharmaceuticals Inc
07/11/202408:00GlobeNewswire Inc.Acumen Pharmaceuticals to Participate in the UBS Global Healthcare ConferenceNASDAQ:ABOSAcumen Pharmaceuticals Inc
07/11/202400:00GlobeNewswire Inc.Acumen Pharmaceuticals Appoints Dr. Amy Schacterle as Chief Regulatory Officer & Head of QualityNASDAQ:ABOSAcumen Pharmaceuticals Inc
06/11/202408:00GlobeNewswire Inc.Acumen Pharmaceuticals to Report Third Quarter Results on Nov. 12, 2024NASDAQ:ABOSAcumen Pharmaceuticals Inc
31/10/202423:05GlobeNewswire Inc.Acumen Pharmaceuticals Presents Innovative Trial Screening Advancements Utilizing pTau217 Assay in Phase 2 Study of Sabirnetug for Early Alzheimer’s Disease at the 17th Annual Clinical Trials on Alzheimer’s Disease ConferenceNASDAQ:ABOSAcumen Pharmaceuticals Inc
23/10/202423:00GlobeNewswire Inc.Acumen Pharmaceuticals to Deliver Late-Breaking Presentation at 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) ConferenceNASDAQ:ABOSAcumen Pharmaceuticals Inc
01/10/202406:00GlobeNewswire Inc.Acumen Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual ConferenceNASDAQ:ABOSAcumen Pharmaceuticals Inc
26/09/202422:00GlobeNewswire Inc.Acumen Pharmaceuticals Extends Collaboration with Lonza to Add Drug Product Manufacturing of Sabirnetug for Early Alzheimer’s DiseaseNASDAQ:ABOSAcumen Pharmaceuticals Inc
26/09/202406:00GlobeNewswire Inc.Acumen Pharmaceuticals to Host Virtual R&D Day on Oct. 2, 2024NASDAQ:ABOSAcumen Pharmaceuticals Inc
04/09/202406:00GlobeNewswire Inc.Acumen Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investor ConferenceNASDAQ:ABOSAcumen Pharmaceuticals Inc
14/08/202406:42Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABOSAcumen Pharmaceuticals Inc
13/08/202421:48Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABOSAcumen Pharmaceuticals Inc
13/08/202421:00GlobeNewswire Inc.Acumen Pharmaceuticals Reports Second Quarter 2024 Financial Results and Business HighlightsNASDAQ:ABOSAcumen Pharmaceuticals Inc
07/08/202406:00GlobeNewswire Inc.Acumen Pharmaceuticals to Report Second Quarter Results on August 13, 2024NASDAQ:ABOSAcumen Pharmaceuticals Inc
29/07/202421:00GlobeNewswire Inc.Acumen Pharmaceuticals Announces First Subject Dosed in Phase 1 Study of Subcutaneous Sabirnetug (ACU193) for Early Alzheimer’s DiseaseNASDAQ:ABOSAcumen Pharmaceuticals Inc
28/07/202421:30GlobeNewswire Inc.Acumen Pharmaceuticals Presents Patient Experience and Biomarker Data from Phase 1 INTERCEPT-AD Study at the Alzheimer’s Association International Conference (AAIC®) 2024NASDAQ:ABOSAcumen Pharmaceuticals Inc
11/06/202406:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABOSAcumen Pharmaceuticals Inc
11/06/202406:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABOSAcumen Pharmaceuticals Inc
11/06/202406:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABOSAcumen Pharmaceuticals Inc
11/06/202406:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABOSAcumen Pharmaceuticals Inc
11/06/202406:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABOSAcumen Pharmaceuticals Inc
06/06/202406:36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABOSAcumen Pharmaceuticals Inc
15/05/202406:47Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABOSAcumen Pharmaceuticals Inc
14/05/202421:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABOSAcumen Pharmaceuticals Inc
14/05/202421:00GlobeNewswire Inc.Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business HighlightsNASDAQ:ABOSAcumen Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ABOS

Your Recent History

BIT
HER
Hera
HITB
ALPHAUSD
Alpha Venture DAO
BITMOT
802380
Austria Tf 1,5% Nv86 Eur
NYSE
NRUC
National Rural Utilities...
AQSE
ALSP
Ace Liberty & Stone
NYSE
NMO
AMEX
TOPT
iShares Top 20 US Stocks...
COIN
TRUMPLOSEUST
Trump Loses Token
NASDAQ
WOK
WORK Medical Technology
NYSE
WEAV
Weave Communications
DBI
I1CG
Xtr MSCI Japan ESG UCITS...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved